Epitrack
Recife
About Epitrack
Epitrack develops a tool designed to assess and track changes in cognitive function in people with epilepsy. It uses a short list of critical questions and visual indicators to assist healthcare professionals (HCPs) in detecting problems with attention and executive function. The screening tool when used repeatedly, allows HCPs to track the course of cognition in epilepsy patients in parallel with changes to anti-epileptic drug treatment, such as first treatment, add-on therapy, drug withdrawal and drug changes. Onocio Leal Neto and Jones Albuquerque founded it on July 20, 2013, with its headquarters in Recife in Brazil.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $768.2K
- Funding stage: Seed
- Last round: Seed (Jan 2017)
- Website: epitrack.com.br
- Phone: +55 81 3038.2185
Industries & Categories
Emergency Medicine, Health Care, Health Diagnostics, Medical, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/epitrack-178313 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.